Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials
伊克珠单抗治疗中重度银屑病5年疗效和安全性:UNCOVER-1和UNCOVER-2 III期随机对照试验的长期结果
期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-020-00367-x
Leonardi, Craig; Reich, Kristian; Foley, Peter; Torii, Hideshi; Gerdes, Sascha; Guenther, Lyn; Gooderham, Melinda; Ferris, Laura K; Griffiths, Christopher E M; ElMaraghy, Hany; Crane, Heidi; Patel, Himanshu; Burge, Russel; Gallo, Gaia; Shrom, David; Leung, Ann; Lin, Chen-Yen; Papp, Kim